Concert Pharmaceuticals, Inc. Liabilities Assumed
Concert Pharmaceuticals, Inc. reported Liabilities Assumed of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2016-05-05
- Concert Pharmaceuticals, Inc. liabilities assumed for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Concert Pharmaceuticals, Inc. liabilities assumed for the quarter ending 2015-03-31 was $276.00K, a 29.95% decline year-over-year.
- Concert Pharmaceuticals, Inc. liabilities assumed for the quarter ending 2014-03-31 was $394.00K.
- Concert Pharmaceuticals, Inc. liabilities assumed for the quarter ending 2013-12-31 was $182.00K.
- Concert Pharmaceuticals, Inc. liabilities assumed for fiscal 2015 was $0.00.
- Concert Pharmaceuticals, Inc. liabilities assumed for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Concert Pharmaceuticals, Inc. liabilities assumed for fiscal 2013 was $475.00K.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-03-01 | |||
| 2015-03-31 | $276.00K 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-01 | |||
| 2014-03-31 | $394.00K 10-Q · filed 2015-05-11 | $576.00K derived: sum of 2 quarters · filed 2016-03-01 | $732.00K derived: sum of 3 quarters · filed 2016-03-01 | |
| 2013-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $338.00K derived: sum of 2 quarters · filed 2016-03-01 | $475.00K 10-K · filed 2016-03-01 | |
| 2013-09-30 | $156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $293.00K 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $137.00K 10-Q · filed 2014-08-12 |